The second receptor binding site of the globular head of the newcastle disease virus hemagglutinin-neuraminidase activates the stalk of multiple paramyxovirus receptor binding proteins to trigger fusion

Journal of Virology

Volumn 86, Issue 10, 2012, Pages 5730-5741

  Porotto, Matteo ^a   Salah, Zuhair ^a,b   DeVito, Ilaria ^a   Talekar, Aparna ^a   Palmer, Samantha G ^a   Xu, Rui ^c   Wilson, Ian A ^c   Moscona, Anne ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Department of Molecular Biology and Genetics   (Qatar)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; HN PROTEIN; HUMAN PARAINFLUENZA VIRUS 3 RECEPTOR BINDING PROTEIN; HYBRID PROTEIN; NIPAH VIRUS RECEPTOR BINDING PROTEIN; UNCLASSIFIED DRUG; VIRUS RECEPTOR; ZANAMIVIR;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NEWCASTLE DISEASE PARAMYXOVIRUS; NIPAH VIRUS; NONHUMAN; PARAINFLUENZA VIRUS 3; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE;

BINDING SITES; CARRIER PROTEINS; CELL LINE; HN PROTEIN; HUMANS; NEWCASTLE DISEASE VIRUS; PARAMYXOVIRIDAE INFECTIONS; PARAMYXOVIRINAE; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, VIRUS; VIRAL FUSION PROTEINS; VIRAL PROTEINS; VIRUS INTERNALIZATION;

HUMAN PARAINFLUENZA VIRUS 3; NEWCASTLE DISEASE VIRUS; NIPAH VIRUS; PARAMYXOVIRIDAE;

EID: 84861303416     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06793-11     Document Type: Article

References (69)

1. Afonine PV, Grosse-Kunstleve RW, Adams PD. 2005. A robust bulksolvent correction and anisotropic scaling procedure. Acta Crystallogr. D Biol. Crystallogr. 61:850-855.
2. Aguilar HC, Aspericueta V, Robinson LR, Aanensen KE, Lee B. 2010. A quantitative and kinetic fusion protein-triggering assay can discern distinct steps in the Nipah virus membrane fusion cascade. J. Virol. 84:8033-8041.
3. Aguilar HC, et al. 2006. N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry. J. Virol. 80:4878-4889.
4. Alymova IV, et al. 2008. Loss of the N-linked glycan at residue 173 of human parainfluenza virus type 1 hemagglutinin-neuraminidase exposes a second receptor-binding site. J. Virol. 82:8400-8410.
5. Bishop KA, et al. 2008. Residues in the stalk domain of the hendra virus G glycoprotein modulate conformational changes associated with receptor binding. J. Virol. 82:11398-11409.
6. Bonaparte MI, et al. 2005. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc. Natl. Acad. Sci. U. S. A. 102:10652-10657.
7. Bose S, et al. 2011. Structure and mutagenesis of the parainfluenza virus 5 hemagglutinin-neuraminidase stalk domain reveals a four-helix bundle and the role of the stalk in fusion promotion. J. Virol. 85:12855-12866.
8. Bousse T, Takimoto T. 2006. Mutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutininneuraminidase protein. J. Virol. 80:9009-9016.
9. Bousse TL, et al. 2004. Biological significance of the second receptor binding site of Newcastle disease virus hemagglutinin-neuraminidase protein. J. Virol. 78:13351-13355.
10. Chaiwatpongsakorn S, Epand RF, Collins PL, Epand RM, Peeples ME. 2011. Soluble respiratory syncytial virus fusion protein in the fully cleaved, pretriggered state is triggered by exposure to low-molarity buffer. J. Virol. 85:3968-3977.
11. Connaris H, et al. 2002. Probing the sialic acid binding site of the hemagglutinin-neuraminidase of Newcastle disease virus: identification of key amino acids involved in cell binding, catalysis, and fusion. J. Virol. 76: 1816-1824.
12. Corey EA, Iorio RM. 2007. Mutations in the stalk of the measles virus hemagglutinin protein decrease fusion but do not interfere with virusspecific interaction with the homologous fusion protein. J. Virol. 81: 9900-9910.
13. Corey EA, Mirza AM, Levandowsky E, Iorio RM. 2003. Fusion deficiency induced by mutations at the dimer interface in the Newcastle disease virus hemagglutinin-neuraminidase is due to a temperaturedependent defect in receptor binding. J. Virol. 77:6913-6922.
14. Crennell S, Takimoto T, Portner A, Taylor G. 2000. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat. Struct. Biol. 7:1068-1074.
15. Deng R, Wang Z, Mirza A, Iorio R. 1995. Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike. Virology 209:457-469.
16. Dutch RE. 2010. Entry and fusion of emerging paramyxoviruses. PLoS Pathog. 6:e1000881.
17. Eckert DM, Kim PS. 2001. Mechanisms of viral membrane fusion and its inhibition. Annu. Rev. Biochem. 70:777-810.
18. Emsley P, Lohkamp B, Scott WG, Cowtan K. 2010. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66:486-501.
19. Farzan SF, et al. 2011. Premature activation of the paramyxovirus fusion protein before target cell attachment with corruption of the viral fusion machinery. J. Biol. Chem. 286:37945-37954.
20. Greengard O, Poltoratskaia N, Leikina E, Zimmerberg J, Moscona A. 2000. The anti-influenza virus agent 4-GU-DANA (Zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA. J. Virol. 74:11108-11114.
21. Harrison SC. 2008. Viral membrane fusion. Nat. Struct. Mol. Biol. 15: 690-698.
22. Hashiguchi T, et al. 2011. Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM. Nat. Struct. Mol. Biol. 18:135-141.
23. Iorio RM, et al. 2001. Structural and functional relationship between the receptor recognition and neuraminidase activities of the Newcastle disease virus hemagglutinin-neuraminidase protein: receptor recognition is dependent on neuraminidase activity. J. Virol. 75:1918-1927.
24. Iorio RM, Mahon PJ. 2008. Paramyxoviruses: different receptors- different mechanisms of fusion. Trends Microbiol. 16:135-137.
25. Iorio RM, Melanson VR, Mahon PJ. 2009. Glycoprotein interactions in paramyxovirus fusion. Future Virol. 4:335-351.
26. Lamb RA, Paterson RG, Jardetzky TS. 2006. Paramyxovirus membrane fusion: lessons from the F andHNatomic structures. Virology 344:30-37.
27. Latger-Cannard V, et al. 2000. Determination of polymorphonuclear neutrophil adhesion receptors. Effect of pre-analytic factors. J. Mal. Vasc. 25:181-186. (In French.)
28. Latger-Cannard V, et al. 2000. Use of standard for quantitation of adhesion of polynuclear neutrophils by flow cytometry. Ann. Biol. Clin. (Paris) 58:337-343. (In French.)
29. Lawrence MC, et al. 2004. Structure of the haemagglutininneuraminidase from human parainfluenza virus type III. J. Mol. Biol. 335:1343-1357.
30. Lee B, Ataman ZA. 2011. Modes of paramyxovirus fusion: a Henipavirus perspective. Trends Microbiol. 19:389-399.
31. Lee KK, et al. 2011. Capturing a fusion intermediate of influenza hemagglutinin with a cholesterol-conjugated peptide: a new antiviral strategy for influenza virus. J. Biol. Chem. 286:42141-42149.
32. Li J, Quinlan E, Mirza A, Iorio RM. 2004. Mutated form of the Newcastle disease virus hemagglutinin-neuraminidase interacts with the homologous fusion protein despite deficiencies in both receptor recognition and fusion promotion. J. Virol. 78:5299-5310.
33. Mahon PJ, Mirza AM, Iorio RM. 2011. Role of the two sialic acid binding sites on the Newcastle disease virus HN protein in triggering the interaction with the F protein required for the promotion of fusion. J. Virol. 85:12079-12082.
34. Mirza AM, et al. 2011. Triggering of the Newcastle disease virus fusion protein by a chimeric attachment protein that binds to Nipah virus receptors. J. Biol. Chem. 286:17851-17860.
35. Mishin VP, et al. 2010. N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site. J. Virol. 84:3094-3100.
36. Moosmann P, Rusconi S. 1996. Alpha complementation of LacZ in mammalian cells. Nucleic Acids Res. 24:1171-1172.
37. Moscona A. 2005. Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease. J. Clin. Invest. 115:1688-1698.
38. Moscona A, Peluso R. 1991. Properties of the human parainfluenza virus type 3 RNA polymerase/replicase in vitro: consensus with other negativestranded RNA viruses. J. Virol. 65:4470-4474.
39. Moscona A, Peluso RW. 1992. Fusion properties of cells infected with human parainfluenza virus type 3: receptor requirements for viral spread and virus-mediated membrane fusion. J. Virol. 66:6280-6287.
40. Moscona A, Peluso RW. 1993. Relative affinity of the human parainfluenza virus 3 hemagglutinin-neuraminidase for sialic acid correlates with virus-induced fusion activity. J. Virol. 67:6463-6468.
41. Murrell M, Porotto M, Weber T, Greengard O, Moscona A. 2003. Mutations in human parainfluenza virus type 3 HN causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (zanamivir). J. Virol. 77:309-317.
42. Navaratnarajah CK, et al. 2011. The heads of the measles virus attachment protein move to transmit the fusion-triggering signal. Nat. Struct. Mol. Biol. 18:128-134.
43. Negrete OA, et al. 2005. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 436:401-405.
44. Noyce RS, et al. 2011. Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog. 7:e1002240.
45. Paal T, et al. 2009. Probing the spatial organization of measles virus fusion complexes. J. Virol. 83:10480-10493.
46. Palermo L, et al. 2009. Human parainfluenza virus infection of the airway epithelium: the viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity. J. Virol. 83:6900-6908.
47. Palermo LM, Porotto M, Greengard O, Moscona A. 2007. Fusion promotion by a paramyxovirus hemagglutinin-neuraminidase protein: pH modulation of receptor avidity of binding sites I and II. J. Virol. 81: 9152-9161.
48. Plemper RK, Hammond AL, Gerlier D, Fielding AK, Cattaneo R. 2002. Strength of envelope protein interaction modulates cytopathicity of measles virus. J. Virol. 76:5051-5061.
49. Porotto M, et al. 2011. Spring-loaded model revisited: Paramyxovirus fusion requires engagement of a receptor binding protein beyond initial triggering of the fusion protein. J. Virol. 85:12867-12880.
50. Porotto M, et al. 2006. Paramyxovirus receptor-binding molecules: engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site. J. Virol. 80:1204-1213.
51. Porotto M, Fornabaio M, Kellogg G, Moscona A. 2007. A second receptor binding site on the human parainfluenza 3 hemagglutininneuraminidase contributes to activation of the fusion mechanism. J. Virol. 81:3216-3228.
52. Porotto M, Greengard O, Poltoratskaia N, Horga M-A, Moscona A. 2001. Human parainfluenza virus type 3 HN-receptor interaction: the effect of 4-GU-DANA on a neuraminidase-deficient variant. J. Virol. 75: 7481-7488.
53. Porotto M, Murrell M, Greengard O, Doctor L, Moscona A. 2005. Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein. J. Virol. 79:2383-2392.
54. Porotto M, et al. 2004. Inhibition of parainfluenza type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites. J. Virol. 78:13911-13919.
55. Porotto M, Murrell M, Greengard O, Moscona A. 2003. Triggering of human parainfluenza virus 3 fusion protein(F) by the hemagglutininneuraminidase (HN): an HN mutation diminishing the rate of F activation and fusion. J. Virol. 77:3647-3654.
56. Porotto M, Palmer SG, Palermo LM, Moscona A. 2012. Mechanism of fusion triggering by human parainfluenza virus type III: communication between the viral glycoproteins during entry. J. Biol. Chem. 287:778-793.
57. Porotto M, Yokoyama C, Orefice G, Kim H-S, Moscona A. 2009. Kinetic dependence of paramyxovirus entry inhibition. J. Virol. 83:6947-6951.
58. Ryan C, et al. 2006. Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus. Glycoconj. J. 23:135-141.
59. Sapir A, Avinoam O, Podbilewicz B, Chernomordik LV. 2008. Viral and developmental cell fusion mechanisms: conservation and divergence. Dev. Cell 14:11-21.
60. Smith EC, Dutch RE. 2010. Side chain packing below the fusion peptide strongly modulates triggering of the Hendra virus F protein. J. Virol. 84: 10928-10932.
61. Smith EC, Popa A, Chang A, Masante C, Dutch RE. 2009. Viral entry mechanisms: the increasing diversity of paramyxovirus entry. FEBS J. 276: 7217-7227.
62. Smith KB, Ellis SA. 1999. Standardisation of a procedure for quantifying surface antigens by indirect immunofluorescence. J. Immunol. Methods 228:29-36.
63. Wang Z, Mirza AM, Li J, Mahon PJ, Iorio RM. 2004. An oligosaccharide at the C-terminus of the F-specific domain in the stalk of the human parainfluenza virus 3 hemagglutinin-neuraminidase modulates fusion. Virus Res. 99:177-185.
64. Weissenhorn W, Hinz A, Gaudin Y. 2007. Virus membrane fusion. FEBS Lett. 581:2150-2155.
65. White JM, Delos SE, Brecher M, Schornberg K. 2008. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit. Rev. Biochem. Mol. Biol. 43:189-219.
66. Yanagi Y, Takeda M, Ohno S, Hashiguchi T. 2009. Measles virus receptors. Curr. Top. Microbiol. Immunol. 329:13-30.
67. Yuan P, et al. 2011. Structure of the Newcastle disease virus hemagglutinin-neuraminidase (HN) ectodomain reveals a four-helix bundle stalk. Proc. Natl. Acad. Sci. U. S. A. 108:14920-14925.
68. Yuan P, et al. 2005. Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose. Structure 13:803-815.
69. Zaitsev V, et al. 2004. Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion. J. Virol. 78: 3733-3741.